231 results match your criteria: "Corrigan-Minehan Heart Center.[Affiliation]"
J Am Coll Cardiol
May 2022
Cardiac Surgery Division, Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
The incidence of injection drug use-associated infective endocarditis has been increasing rapidly over the last decade. Patients with drug use-associated infective endocarditis present an increasingly common clinical challenge with poor long-term outcomes and high reinfection and readmission rates. Their care raises issues unique to this population, including antibiotic selection and administration, indications for and ethical issues surrounding surgical intervention, and importantly management of the underlying substance use disorder to minimize the risk of reinfection.
View Article and Find Full Text PDFCurr Heart Fail Rep
August 2022
Cardiovascular Research Center, Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Boston, MA, 02129, USA.
Purpose Of Review: We review the clinical benefits of altering myocardial substrate metabolism in heart failure.
Recent Findings: Modulation of cardiac substrates (fatty acid, glucose, or ketone metabolism) offers a wide range of therapeutic possibilities which may be applicable to heart failure. Augmenting ketone oxidation seems to offer great promise as a new therapeutic modality in heart failure.
JACC Basic Transl Sci
May 2022
Corrigan Minehan Heart Center, Division of Cardiology, Cardiovascular Research Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Cardiovasc Revasc Med
August 2023
Cardiovascular Division, Department of Medicine, NorthShore University Health System, Evanston, IL, United States of America. Electronic address:
Background: The incremental use of transcatheter aortic valve replacement will inexorably lead to structural valve deterioration and the need for both a second and third valvular interventions, raising the question of feasibility.
Case Summary: We present the case of a 76-year-old man that presented with cardiogenic shock refractory to inotropic support. His workup revealed severe bioprosthetic aortic regurgitation 5 years after undergoing transcatheter aortic valve-in-valve implantation.
Am Heart J
September 2022
Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, NY.
Background: For patients with symptomatic atrial fibrillation (AF), physicians typically offer AF ablation for symptom relief; however, patients often anticipate/expect a life free from anticoagulation. This belief puts patients at increased risk of stroke due to the potential for asymptomatic AF postablation if anticoagulation is ceased contrary to clinical guidelines. Although the WATCHMAN device has been FDA-approved to decrease the risk of thromboembolism from the left atrial appendage (LAA) in patients with an appropriate rationale to avoid oral anticoagulation, it has not been well-studied following AF ablation.
View Article and Find Full Text PDFJACC CardioOncol
March 2022
Cardiovascular Institute and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Background: Obesity and cardiometabolic dysfunction have been associated with cancer risk and severity. Underlying mechanisms remain unclear.
Objectives: The aim of this study was to examine associations of obesity and related cardiometabolic traits with incident cancer.
Open Forum Infect Dis
March 2022
Massachusetts General Hospital, Boston, Massachusetts, USA.
Background: Consensus guidelines recommend multidisciplinary models to manage infective endocarditis, yet often do not address the unique challenges of treating people with drug use-associated infective endocarditis (DUA-IE). Our center is among the first to convene a Drug Use Endocarditis Treatment (DUET) team composed of specialists from Infectious Disease, Cardiothoracic Surgery, Cardiology, and Addiction Medicine.
Methods: The objective of this study was to describe the demographics, infectious characteristics, and clinical outcomes of the first cohort of patients cared for by the DUET team.
Vasc Med
April 2022
Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Circ Heart Fail
February 2022
CardioVascular Institute and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA (D.W., E.E.L., J.K.W., J.E.H.).
Background: The pulmonary artery pulsatility index (PAPi), calculated from the ratio of the pulmonary artery pulse pressure to right atrial pressure, is a predictor of right ventricular failure after inferior myocardial infarction and left ventricular assist device implantation. Whether PAPi is associated with adverse outcomes across a heterogeneous population is unknown.
Methods: We examined consecutive patients undergoing right heart catheterization between 2005 and 2016 in a hospital-based cohort.
Ann Thorac Surg
June 2023
Division of Cardiac Surgery and Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Surgery, Harvard Medical School, Boston, Massachusetts; Cardiac Surgery Clinical Service, Mass General Brigham, 55 Fruit St, Boston, MA 02114. Electronic address:
Circulation
April 2022
Corrigan-Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (H.L., L.E.T., X.L., M.H.H., C.X., J.G., S.T., G.L., A.Y., R.R., M.G.S., S.D., J.M.G.-R., A.R.).
Background: The heart grows in response to pathological and physiological stimuli. The former often precedes cardiomyocyte loss and heart failure; the latter paradoxically protects the heart and enhances cardiomyogenesis. The mechanisms underlying these differences remain incompletely understood.
View Article and Find Full Text PDFJ Cardiothorac Vasc Anesth
May 2022
Department of Anesthesia, Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Electronic address:
Objectives: To examine the use of inhaled nitric oxide (iNO) and inhaled epoprostenol (iPGI2) before and after implementation of an iPGI2-preferential protocol and the associated cost differences after rollout.
Design: A single-center, retrospective analysis.
Setting: A quaternary university hospital.
Heart
August 2022
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
J Thorac Cardiovasc Surg
October 2022
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn. Electronic address:
Objective: Approximately 40% of lung transplants for chronic obstructive pulmonary disease (COPD) in the lung allocation score era are single lung transplantations (SLTs). We hypothesized that double lung transplantation (DLT) results in superior survival, but that mortality on the waitlist may compel clinicians to perform SLT. We investigated both waitlist mortality in COPD patients with restricted versus unrestricted listing preferences and posttransplant survival in SLT versus DLT to identify key predictors of mortality.
View Article and Find Full Text PDFAnn Cardiothorac Surg
November 2021
Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston, MA, USA.
J Thorac Cardiovasc Surg
August 2023
Harvard Medical School, Boston, Mass; Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston Mass; Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston Mass.
Objectives: Drug use-associated infective endocarditis is a rapidly growing clinical problem. Although operative outcomes are generally satisfactory, reinfection secondary to recurrent substance use is distressingly common, negatively affects long-term survival, generates practical and ethical challenges, and creates potential conflict among care team members. We established a Drug Use Endocarditis Treatment team including surgeons, infectious disease, and addiction medicine experts specifically focused on the unique complexities of drug use-associated infective endocarditis.
View Article and Find Full Text PDFArterioscler Thromb Vasc Biol
February 2022
Cardiovascular Research Center and Corrigan Minehan Heart Center, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (R.M., C.J.N., D.W., V.B., S.P., C.S., H.H.S., C.L.L.C., R.L., S.L.B., M.E.L., G.D.L., J.D.R., C.N., J.E.H.).
J Sport Health Sci
December 2021
Cardiovascular Research Center, Division of Cardiology, Corrigan Minehan Heart Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address:
Ann Surg
December 2021
H and S Nichols Distinguished Chair in Surgery, Department of Surgery, Dr. Gewertz Vice President Interventional Services, Vice Dean Academic Affairs, Cedars-Sinai Medical Center, Los Angeles, CA.
J Am Coll Cardiol
November 2021
Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: https://twitter.com/drmalissawood.
Socioeconomic disparities in cardiovascular risk factors and outcomes exist among women, particularly those of minority racial or ethnic backgrounds. Barriers to optimal cardiovascular health begin early in life-with inadequate access to effective contraception, postpartum follow-up, and maternity leave-and result in excess rates of myocardial infarction, stroke, and cardiovascular death in at-risk populations. Contributing factors include reduced access to care, low levels of income and social support, and lack of diversity among cardiology clinicians and within clinical trials.
View Article and Find Full Text PDFJ Card Surg
February 2022
Division of Cardiac Surgery, Massachusetts General Hospital and Corrigan Minehan Heart Center, Boston, Massachusetts, USA.
Objective: Aortic valve disease is a risk factor for atrial fibrillation (AF), and AF is associated with increased late mortality and morbidity after cardiac surgery. The evolution of alternative approaches to AF prophylaxis, including less invasive technologies and medical therapies, has altered the balance between risk and potential benefit for prophylactic intervention at the time of surgical aortic valve replacement (SAVR). Such interventions impose incremental risk, however, making an understanding of predictors of new onset AF that persists beyond the perioperative episode relevant.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
April 2023
Division of Cardiac Surgery, Massachusetts General Hospital and Corrigan Minehan Heart Center, Boston, Mass.
Objective: Current cardiac surgery risk models do not address a substantial fraction of procedures. We sought to create models to predict the risk of operative mortality for an expanded set of cases.
Methods: Four supervised machine learning models were trained using preoperative variables present in the Society of Thoracic Surgeons (STS) data set of the Massachusetts General Hospital to predict and classify operative mortality in procedures without STS risk scores.
Hypertension
November 2021
Brigham and Women's Hospital, Heart & Vascular Center (M.P., M.V., T.B.-S., D.L.B.), Harvard Medical School, Boston, MA.
[Figure: see text].
View Article and Find Full Text PDFJ Am Coll Cardiol
October 2021
Cardiovascular Research Center, Cardiology Division, Corrigan Minehan Heart Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
JACC Case Rep
September 2021
Cardiac Arrythmia Service, Corrigan Minehan Heart Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
A 53-year-old man with a subcutaneous implantable cardioverter-defibrillator (S-ICD) presented with inappropriate shocks. He underwent device extraction, and the lead was freed using a rotating mechanical dilator sheath. As patients with S-ICDs get older, extractions will become more complicated and more common.
View Article and Find Full Text PDF